Biogened S.A.

WSE:BGD Rapport sur les actions

Capitalisation boursière : zł54.0m

Biogened Bilan de santé

Santé financière contrôle des critères 4/6

Biogened possède un total de capitaux propres de PLN39.3M et une dette totale de PLN23.3M, ce qui porte son ratio d'endettement à 59.2%. Son actif total et son passif total sont PLN87.0M et de PLN47.7M. L'EBIT de Biogened est PLN8.4M ce qui fait que son ratio de couverture des intérêts 3.7. Elle dispose de liquidités et de placements à court terme de PLN6.2M.

Informations clés

59.2%

Ratio d'endettement

zł23.29m

Dette

Ratio de couverture des intérêts3.7x
Argent liquidezł6.16m
Fonds propreszł39.32m
Total du passifzł47.66m
Total des actifszł86.97m

Mises à jour récentes de la santé financière

Recent updates

Biogened (WSE:BGD) Takes On Some Risk With Its Use Of Debt

Nov 06
Biogened (WSE:BGD) Takes On Some Risk With Its Use Of Debt

A Piece Of The Puzzle Missing From Biogened S.A.'s (WSE:BGD) 25% Share Price Climb

Aug 28
A Piece Of The Puzzle Missing From Biogened S.A.'s (WSE:BGD) 25% Share Price Climb

Impressive Earnings May Not Tell The Whole Story For Biogened (WSE:BGD)

Aug 22
Impressive Earnings May Not Tell The Whole Story For Biogened (WSE:BGD)

Investors Give Biogened S.A. (WSE:BGD) Shares A 37% Hiding

May 23
Investors Give Biogened S.A. (WSE:BGD) Shares A 37% Hiding

Here's Why Biogened (WSE:BGD) Has A Meaningful Debt Burden

May 09
Here's Why Biogened (WSE:BGD) Has A Meaningful Debt Burden

Biogened's (WSE:BGD) Promising Earnings May Rest On Soft Foundations

Feb 21
Biogened's (WSE:BGD) Promising Earnings May Rest On Soft Foundations

Is Biogened (WSE:BGD) A Risky Investment?

Feb 01
Is Biogened (WSE:BGD) A Risky Investment?

Biogened S.A. (WSE:BGD) Looks Just Right With A 37% Price Jump

Feb 01
Biogened S.A. (WSE:BGD) Looks Just Right With A 37% Price Jump

We Think Biogened (WSE:BGD) Can Stay On Top Of Its Debt

Jun 30
We Think Biogened (WSE:BGD) Can Stay On Top Of Its Debt

Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Oct 08
Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Is Biogened (WSE:BGD) A Risky Investment?

Jun 29
Is Biogened (WSE:BGD) A Risky Investment?

Does Biogened (WSE:BGD) Have A Healthy Balance Sheet?

Mar 25
Does Biogened (WSE:BGD) Have A Healthy Balance Sheet?

These 4 Measures Indicate That Biogened (WSE:BGD) Is Using Debt Reasonably Well

Dec 09
These 4 Measures Indicate That Biogened (WSE:BGD) Is Using Debt Reasonably Well

Biogened (WSE:BGD) Has A Somewhat Strained Balance Sheet

Jul 29
Biogened (WSE:BGD) Has A Somewhat Strained Balance Sheet

Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Apr 30
Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Is Biogened (WSE:BGD) A Risky Investment?

Jan 24
Is Biogened (WSE:BGD) A Risky Investment?

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de BGD ( PLN52.7M ) dépassent ses passifs à court terme ( PLN23.4M ).

Passif à long terme: Les actifs à court terme de BGD ( PLN52.7M ) dépassent ses passifs à long terme ( PLN24.2M ).


Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de BGD ( 43.6% ) est considéré comme élevé.

Réduire la dette: Le ratio d'endettement de BGD est passé de 40.6% à 59.2% au cours des 5 dernières années.

Couverture de la dette: La dette de BGD est bien couverte par le flux de trésorerie opérationnel ( 20.1% ).

Couverture des intérêts: Les paiements d'intérêts de BGD sur sa dette sont bien couverts par l'EBIT ( 3.7 x couverture).


Bilan


Découvrir des entreprises saines